Ziva Misulovin

4.8k citations
50 papers · 3.4k indexed · h-index 32

Ziva Misulovin

50 papers receiving 3.3k citations

Peers

Ziva Misulovin
Comparison fields: 5 of 113
  • Immunology 1.3k
  • Molecular Biology 1.9k
  • Physiology 91
  • Radiology, Nuclear Medicine and Imaging 352
  • Immunology and Allergy 90
Replace F W Alt with:
F W Alt United States
Peter N. Cockerill United Kingdom
L Hood United States
Jean-Marie Buerstedde Germany
Mitsuaki Yoshida Japan
Scott A. Ness United States
T Nakagawa United States
Gek Kee Sim United States
Patricia A. Blundell United Kingdom
Alan G. Wildeman Canada
Ziva Misulovin relative to F W Alt United States F W Alt's profile →
Citations per field
00.5×
F W Alt · 1×
Citations per year

Countries citing papers authored by Ziva Misulovin

Since Specialization
Citations

This map shows the geographic impact of Ziva Misulovin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziva Misulovin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziva Misulovin more than expected).

Fields of papers citing papers by Ziva Misulovin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziva Misulovin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziva Misulovin. The network helps show where Ziva Misulovin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ziva Misulovin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ziva Misulovin Line = papers co-authored together Ziva Misulovin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202017
2 201815
3 201746
4 201624
5 20167
6 201524
7 201316
8 201384
9 201393
10 201086
11 200992
12 2007171
13 200588
14 200464
15 200126
16 2000105
17 2000106
18 19999
19 199581
20 1993195

About Ziva Misulovin

Ziva Misulovin is a scholar working on Physiology, Immunology and Molecular Biology, having authored 50 papers that have together received 3.4k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (18 papers), T-cell and B-cell Immunology (12 papers), RNA Research and Splicing (12 papers), Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (7 papers), Plant Molecular Biology Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Chromosomal and Genetic Variations (6 papers). The work is most often cited by research in Immunology (1.3k citations), Molecular Biology (1.9k citations) and Physiology (91 citations). Ziva Misulovin has collaborated with scholars based in United States, United Kingdom and New Zealand. Frequent co-authors include Michel C. Nussenzweig, Dale Dorsett, Maria Gause, Heikyung Suh, Robin A. Wallace, Mila Janković, Wong Yu, Mercedes Sanchez, Cheri A. Schaaf and M C Nussenzweig. Their work appears in journals such as The Journal of Experimental Medicine, PLoS Genetics, Molecular and Cellular Biology, Proceedings of the National Academy of Sciences and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026